Related Experiment Video
Updated: Jun 7, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in
Patricia Devaux1, Andrew W Hudacek, Gregory Hodge
1Department of Molecular Medicine, Mayo Clinic and Foundation, Guggenheim 18-01B, 200 First Street SW, Rochester, MN 55905, USA. devaux.patricia@mayo.edu
Abstract:
Measles remains a leading cause of death worldwide among children because it suppresses immune function. The measles virus (MV) P gene encodes three proteins (P, V, and C) that interfere with innate immunity, controlling STAT1, STAT2, mda5, and perhaps other key regulators of immune function. We identified here three residues in the shared domain of the P and V proteins-tyrosine 110, valine 112, and histidine 115-that function to retain STAT1 in the cytoplasm and inhibit interferon transcription. This information was used to generate a recombinant measles virus unable to antagonize STAT1 function (STAT1-blind MV) differing only in these three residues from a wild-type strain of well-defined virulence. This virus was used to assess the relevance of P and V interactions with STAT1 for virulence in primates. When a group of six rhesus monkeys (Macaca mulatta) was inoculated intranasally with STAT1-blind MV, viremia was short-lived, and the skin rash and other clinical signs observed with wild-type MV were absent. The STAT1-blind virus less efficiently controlled the inflammatory response, as measured by enhanced transcription of interleukin-6 and tumor necrosis factor alpha in peripheral blood mononuclear cells from infected hosts. Importantly, neutralizing antibody titers and MV-specific T-cell responses were equivalent in hosts infected with either virus. These findings indicate that efficient MV interactions with STAT1 are required to sustain virulence in a natural host by controlling the inflammatory response against the virus. They also suggest that selectively STAT1-blind MV may have utility as vectors for targeted oncolysis and vaccination.
Insights
Measles virus (MV) antagonizes immune function by controlling STAT1. A modified MV unable to block STAT1 showed reduced virulence in primates, indicating STAT1 interaction is key for MV disease.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Measles virus (MV) is a significant global child health threat due to its immune suppression.
- The MV P gene produces P, V, and C proteins that disrupt innate immunity, targeting key regulators like STAT1.
Purpose of the Study:
- To identify specific MV protein residues essential for STAT1 antagonism.
- To generate a STAT1-blind MV and evaluate its virulence and immunogenicity in a primate model.
Main Methods:
- Site-directed mutagenesis was used to create a recombinant MV (STAT1-blind MV) with altered P and V protein residues (Y110, V112, H115).
- Rhesus monkeys were intranasally inoculated with either wild-type MV or STAT1-blind MV.
- Viral load (viremia), clinical signs, inflammatory markers (IL-6, TNF-alpha), and adaptive immune responses (neutralizing antibodies, T-cells) were assessed.
Main Results:
- STAT1-blind MV exhibited reduced viremia and absent clinical signs (rash) compared to wild-type MV.
- The STAT1-blind virus showed less control over the inflammatory response, with increased IL-6 and TNF-alpha transcription.
- Humoral and cellular immune responses were comparable between groups infected with wild-type and STAT1-blind MV.
Conclusions:
- Efficient interaction between MV proteins (P/V) and STAT1 is crucial for sustaining viral virulence in natural hosts by modulating the inflammatory response.
- Targeted modification of MV to create STAT1-blind strains could offer potential as novel vectors for oncolysis and vaccination.
Related Concept Videos
Respiratory Syncytial Virus Disease
Rabies
The JAK-STAT Signaling Pathway

